A new single patient-use, negative pressure wound therapy system has been launched in the UK.
Mölnlycke Health Care this week announced the UK launch of its Avance Solo system, which has variable pressure settings.
The device weighs 400g and can “easily be carried or worn in a discreet manner, giving patients greater flexibility, mobility and comfort”, according to Mölnlycke.
The company said the device allowed patients to be discharged quickly and continue their treatment at home for up to 60 days – making it more efficient larger, less mobile negative pressure systems.
Steve Atlay, the firm’s global business director for negative pressure wound therapy, said: “Patients now have access to true negative pressure therapy in their home and on the go, without having to experience the unnecessary pain and suffering otherwise associated with this form of treatment.”
“Following a successful launch in the UK, we are also targeting launches across other selected markets during 2014,” he said.
Are you able to Speak Out Safely? Sign our petition to put pressure on your trust to support an open and transparent NHS.